Payor Re-Evaluation On Exondys Positive For Sarepta
March 10, 2017 at 15:21 PM EST
Cowen sees positive trends over payor evaluation and re-evaluation of Sarepta Therapeutics Inc (NASDAQ: SRPT)’s Exondys 51, which ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.